These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34550666)

  • 21. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
    Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
    Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids.
    Beck D; Winzenborg I; Liu M; Degner J; Mostafa NM; Noertersheuser P; Shebley M
    Clin Pharmacokinet; 2022 Apr; 61(4):577-587. PubMed ID: 34878624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranexamic acid: a new option for heavy menstrual bleeding.
    Wilton JM
    Nurs Womens Health; 2012; 16(2):146-150. PubMed ID: 22900772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial.
    Kawahara N; Kawaguchi R; Yamamoto K; Nishikawa K; Matsuoka M; Maehana T; Fukui Y; Yamanaka S; Sugimoto S; Iwai K; Yamada Y; Kurakami H; Hirata T; Takashima R; Suzuki S; Asada K; Kasahara M; Kimura F
    Trials; 2024 Jan; 25(1):68. PubMed ID: 38243317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA.
    Yao X; Stewart EA; Laughlin-Tommaso SK; Heien HC; Borah BJ
    BJOG; 2017 Jan; 124(2):322-330. PubMed ID: 27770484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First Oral Hormone for Treating Prostate Cancer.
    Aschenbrenner DS
    Am J Nurs; 2021 Apr; 121(4):22-23. PubMed ID: 33755620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
    Hoshiai H; Seki Y; Kusumoto T; Kudou K; Tanimoto M
    BMC Womens Health; 2021 Oct; 21(1):375. PubMed ID: 34711224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
    Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HO; Li Y; McKain L; Arjona Ferreira JC; Langenberg AG; Wagman RB; Stewart EA
    Pain Manag; 2023 Apr; 13(4):205-211. PubMed ID: 37183454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids].
    Starczewski A; Iwanicki M
    Ginekol Pol; 2000 Sep; 71(9):1221-5. PubMed ID: 11083008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding.
    de Lange ME; Huirne JAF
    Lancet; 2022 Sep; 400(10356):866-867. PubMed ID: 36116467
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
    Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
    Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women.
    Archer DF; Ng J; Chwalisz K; Chiu YL; Feinberg EC; Miller CE; Feldman RA; Klein CE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31650182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment.
    Lv J; Lin J
    Asian J Androl; 2021; 23(3):229-230. PubMed ID: 33243960
    [No Abstract]   [Full Text] [Related]  

  • 37. Relugolix, Estradiol, and Norethindrone Acetate.
    Am J Health Syst Pharm; 2021 Sep; 78(19):1755-1760. PubMed ID: 34286333
    [No Abstract]   [Full Text] [Related]  

  • 38. Relugolix for the treatment of uterine fibroids.
    Barra F; Seca M; Della Corte L; Giampaolino P; Ferrero S
    Drugs Today (Barc); 2019 Aug; 55(8):503-512. PubMed ID: 31461087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
    Al-Hendy A; Lukes AS; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
    J Comp Eff Res; 2023 Aug; 12(8):e230069. PubMed ID: 37477173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.